European Association for Cancer Research (EACR) Revenue and Competitors
Employee Data
- European Association for Cancer Research (EACR) has 97 Employees.
- European Association for Cancer Research (EACR) grew their employee count by 24% last year.
European Association for Cancer Research (EACR)'s People
Name | Title | Email/Phone |
---|
European Association for Cancer Research (EACR) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 74 | 10% | N/A | N/A |
#2 | $7.5M | 100 | -6% | N/A | N/A |
#3 | $35M | 2758 | 9% | N/A | N/A |
#4 | $15M | 373 | 20% | N/A | N/A |
#5 | $1.7M | 329 | -3% | N/A | N/A |
#6 | $3.5M | 122 | 34% | N/A | N/A |
#7 | $7.5M | 174 | -6% | N/A | N/A |
#8 | $7.5M | 59 | 7% | N/A | N/A |
#9 | N/A | 29 | -24% | N/A | N/A |
#10 | $3.5M | 63 | -7% | N/A | N/A |
What Is European Association for Cancer Research (EACR)?
The European Association for Cancer Research is Europe’s largest professional member society and registered charity for cancer researchers with over 13,000 members worldwide. Membership is open to anyone actively working or studying in cancer research and our members work across the full spectrum of the field, from basic and translational to clinical research.\n\nWe provide a wide range of services to our members, facilitate communication and collaboration, and organise a series of cancer research conferences and congresses where the latest research topics and interaction for participants are the very highest priorities. We also set out to raise the profile of cancer research and cancer researchers in Europe and the need for sustained political and economic support.
keywords:N/AN/A
Total Funding
97
Number of Employees
N/A
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.2M | 97 | 14% | N/A |
#2 | $17.1M | 98 | -2% | N/A |
#3 | $32M | 99 | 1% | N/A |
#4 | $21.4M | 102 | -50% | N/A |
#5 | $34.7M | 105 | 3% | N/A |